Degree and stability of tolerance to penicillin in Streptococcus pyogenes

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
M F Michel, W B van Leeuwen

Abstract

The degree of antibiotic tolerance may be assessed by determining the tolerance percentage of a bacterial strain, defined as the surviving fraction of an inoculum that has been exposed for 24 hours to a high concentration of a beta-lactam antibiotic. In 61 clinical isolates of Streptococcus pyogenes, tolerance percentages ranged from 0 to 0.43. From the slopes of the killing curves it can be deduced that killing starts to be delayed at a tolerance percentage of 0.1. Although a tolerance percentage exceeding 0.1 was observed in 41.4% of the strains, the incidence of clinically relevant forms of tolerance is expected to occur in a smaller fraction of the strains. Tolerance percentages of two strains stored at 20 degrees C, 4 degrees C or -70 degrees C (tolerance percentages 0.43 and 0.36) decreased to 0.03 or less in six weeks. Tolerance percentages could be completely restored in these strains, but not in sensitive strains, by successive selection for this property on penicillin gradients of increasing concentration. In four strains isolated from a family outbreak, identical levels of tolerance percentage could be selected for with the same technique.

References

Feb 26, 1977·Lancet·L D SabathB J Wilkinson
Apr 1, 1987·The Journal of Antimicrobial Chemotherapy·K S Kim, A S Bayer
Apr 1, 1988·The Journal of Pediatrics·K S Kim
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·E TuomanenA Tomasz
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·J C Sherris
Mar 1, 1986·Antimicrobial Agents and Chemotherapy·P R MeylanM P Glauser
May 1, 1985·Reviews of Infectious Diseases·S Handwerger, A Tomasz
May 1, 1984·Antimicrobial Agents and Chemotherapy·W H GoessensM F Michel
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·R O Brennan, D T Durack
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·W H GoessensM F Michel
Dec 1, 1980·Annals of Internal Medicine·D Kaye
Nov 1, 1981·The Journal of Infectious Diseases·K S Kim, B F Anthony

❮ Previous
Next ❯

Citations

Feb 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G J van AsseltC P van Boven
Sep 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J T van der MeerM F Michel
Sep 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G P VoornM F Michel
Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·M P DoreA R Sepulveda
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·C BetriuJ J Picazo
Feb 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G J van AsseltC P van Boven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.